Your search returned 11 results. Subscribe to this search

Not what you expected? Check for suggestions
|
1. 151P Maintenance Therapy using Tyrosine Kinase Inhibitor (erlotinib) or Pemetrexed in metastatic/locally advanced in EGFR Mutation-Negative Lung Cancer: Comparison of Results

by Gupta K | Joshi A | Noronha V | Parthiban SK | Patil V | Janu A | Kaushal R | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

2. 432P QTWiST analysis to compare the benefit of maintenance Erlotinib versus pemetrexed patients with EGFR non mutated NSCLC

by Turkar S [Corresponding author] | Joshi A | Noronha V | Patil V | Sharma M | Vora S | More S | Goud S | Prabhash K.

In Annals of Oncology
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

3. A comparative pharmacokinetic study of 2 pemetrexed formulations in Indian adult chemonaive patients with adenocarcinoma stage III/IV non-small cell lung cancer.

by Kavathiya K | Gurjar M | Patil A | Naik M | Noronha V | Joshi A | Gota V | Prabhash K.

In Clinical Pharmacology in Drug Development
Material type: article Article; Format: print Publisher: Hoboken, NJ :, Wiley 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

4. Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study.

by Gridelli C | de Marinis F | Thomas M | Prabhash K | El Kouri C | Blackhall F | Bustin F | Pujol JL | John WJ | San Antonio B | Zimmermann A | Chouaki N | Visseren-Grul C | Paz-Ares LG.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2014Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

5. Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center.

by Pandey AV | Phillip DS | Noronha V | Joshi A | Janu A | Jambekar N | Kaushal R | Mahajan A | Prabhash K [Corresponding author].

In Indian Journal of Medical and Paediatric Oncology
Material type: article Article; Format: print Publisher: Mumbai : Medknow Publications 2015Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

6. P3.02b-055 Impact of pemetrexed chemotherapy in exon 19 or exon 21 mutated nsclc

by Talreja V | Noronha V | Patil V | Joshi A | Chougule A | Mahajan A | Janu A | Goud S | More S | Karpe A | Ramaswamy A | Pande N | Chandrasekharan A | Goel A | Prabhash K.

In Journal of Thoracic Oncology
Material type: article Article; Format: print Publisher: New York, NY : Elsevier 2017Online access: PDF Availability: Items available for loan: Tata Memorial Hospital (1).

7. Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

by Patil VM | Noronha V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In ESMO Open
Material type: article Article; Format: print Publisher: 2017Availability: Items available for loan: Tata Memorial Hospital (1).

8. Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian Patients.

by Srinivasan M | Chaturvedula A [Corresponding Author] | Fossler MJ | Patil A | Gota V | Prabhash K.

In Journal of Clinical Pharmacology.
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

9. Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/ carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

by Patil V | Noronha V | Joshi A | Chougule A | Bhattacharjee A | Goel A | Talreja V | Menon N | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Mahajan A | Janu A | Purandare N | Kumar P [Corresponding Author].

In Cancer Research, Statistics, and Treatment
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

10. Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer.

by Patil V | Joshi A | Noronha V | Kanan S | Agarwala V | Chougule A | Bhattacharjee A | Chandrasekharan A | Pande N | Simha V | Goud S | More S | Kumar R | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding Author].

In Oncotarget
Material type: article Article; Format: print Publisher: 2019Availability: Items available for loan: Tata Memorial Hospital (1).

11. Tyrosine kinase inhibitor versus physician choice chemotherapy in second-line epidermal growth factor receptor mutation non-small cell lung cancer: Post hoc analysis of randomized control trial

by Noronha V | Pandey A | Patil V | Joshi A | Choughule AB | Bhattacharjee A | Kumar R | Goud S | More S | Ramaswamy A | Karpe A | Pande N | Chandrasekharan A | Goel A | Talreja V | Mahajan A | Janu A | Purandare N | Prabhash K [Corresponding author].

In Indian Journal of Medical and Paediatric Oncology
Material type: article Article; Format: print Publisher: 2018Availability: Items available for loan: Tata Memorial Hospital (1).

Powered by Koha